Category: Cowen

  • CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan By Investing.com

    Investing.com – Analysts at TD Cowen raised their rating on CVS Health (NYSE:) to “buy” from “hold,” citing changes to Medicare Advantage plan benefits for 2025 announced earlier this week. Along with peers like Humana (NYSE:) and Cigna (NYSE:), CVS unveiled details of next year’s government-backed health insurance plans for…

  • CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan By Investing.com

    Investing.com – Analysts at TD Cowen raised their rating on CVS Health (NYSE:) to “buy” from “hold,” citing changes to Medicare Advantage plan benefits for 2025 announced earlier this week. Along with peers like Humana (NYSE:) and Cigna (NYSE:), CVS unveiled details of next year’s government-backed health insurance plans for…

  • 10X Genomics hold rating reiterated by TD Cowen By Investing.com

    TD Cowen maintained a Hold rating on 10X Genomics (NASDAQ:TXG) with a firm price target of $20.00. The decision came after 10X Genomics revealed plans at an industry event to introduce new single-cell (SC) products in the fourth quarter. These offerings are designed to be more cost-effective, with an emphasis…

  • Netflix target raised at TD Cowen ahead of earnings By Investing.com

    TD Cowen analysts are bullish on Netflix (NASDAQ:) earnings, citing strong subscriber growth and a thriving advertising business as key factors. The bank expects Netflix to add 5.19 million paid subscribers in the second quarter of 2024, beating analysts’ consensus of 3.72 million. The growth is driven by paid engagement…